MIRATI THERAPEUTICS INC (MRTX) Stock Income Statement
USA - NASDAQ:MRTX - US60468T1051 - Common Stock
58.7 USD
-0.1 (-0.17%)
58.99 USD
+0.29 (+0.49%)
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 38.19M | 12.44M | 72.09M | 13.40M | 3.34M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | 4.39M | 600.00K | null | null | null | |||
| Gross Profit | 33.80M | 11.84M | null | null | null | |||
| Operating Expenses | 798.67M | 771.43M | 645.27M | 382.76M | 225.44M | |||
| Research and Development | 506.88M | 531.63M | 508.59M | 299.35M | 182.87M | |||
| Selling, General, and Administrative Expenses | 291.80M | 239.80M | 136.68M | 83.41M | 42.57M | |||
| Operating Income | -764.86M | -759.59M | -573.18M | -369.36M | -222.10M | |||
| Interest Income/Expense | null | null | 5.30M | 11.40M | 8.80M | |||
| Other Income/Expense | 37.15M | 19.23M | -5.30M | 30.00K | 50.00K | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -725.62M | -740.36M | -578.49M | -357.94M | -213.26M | |||
| Income Tax | null | 510.00K | 3.30M | null | null | |||
| Net Income | -725.88M | -740.87M | -581.78M | -357.94M | -213.26M | |||
| EBITDA | -760.67M | -756.66M | -571.40M | -368.72M | -221.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -12.22 | -13.18 | -11.21 | -7.96 | -5.69 | |||
| Non GAAP EPS | -12.22 | -13.18 | -11.17 | -7.949999999999999 | -5.64 | |||
| Statistics | ||||||||
| Gross Profit Margin | 88.50% | 95.18% | N/A | N/A | N/A | |||
| Profit Margin | -1900.71% | -5955.55% | -807.02% | -2671.19% | -6385.03% | |||
| Operating Profit Margin | -2002.78% | -6106.03% | -795.09% | -2756.42% | -6649.70% | |||
All data in USD